Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BEKE-W
02423
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 1.10%2.55B | 14.99%2.52B | 33.23%2.19B | 85.69%1.65B | -13.71%887.1M | 9.13%1.03B | 33.28%942.05M | 28.84%706.81M | 5.75%548.58M | 10.61%518.76M |
| Revenue from customers | 1.10%2.55B | 14.99%2.52B | 33.23%2.19B | 85.69%1.65B | -13.71%887.1M | 9.13%1.03B | 33.28%942.05M | 28.84%706.81M | 5.75%548.58M | 10.61%518.76M |
| Cash paid | -0.02%-2.41B | -12.84%-2.41B | -35.82%-2.14B | -93.44%-1.57B | 13.70%-812.68M | -9.19%-941.63M | -42.09%-862.35M | -23.42%-606.9M | -8.05%-491.72M | -4.61%-455.09M |
| Payments to suppliers for goods and services | -0.02%-2.41B | -12.84%-2.41B | -35.82%-2.14B | -93.44%-1.57B | 13.70%-812.68M | -9.19%-941.63M | -42.09%-862.35M | -23.42%-606.9M | -8.05%-491.72M | -4.61%-455.09M |
| Direct dividend received | 66.01%7.26M | 157.20%4.38M | 106.18%1.7M | --825K | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest paid | 23.25%-8.86M | 9.14%-11.55M | -85.86%-12.71M | -44.34%-6.84M | -28.44%-4.74M | -78.82%-3.69M | -292.21%-2.06M | 27.35%-526K | -103.94%-724K | 80.00%-355K |
| Direct interest received | 36.25%2.74M | 10.54%2.01M | 1,740.40%1.82M | 147.50%99K | -61.17%40K | -85.22%103K | -24.65%697K | 31.77%925K | 5.09%702K | 409.92%668K |
| Direct tax refund paid | 35.72%-7.68M | -126.87%-11.95M | 512.37%44.47M | 55.41%-10.78M | 3.96%-24.18M | -33.82%-25.18M | 8.82%-18.81M | -238.47%-20.63M | -268.12%-6.1M | ---1.66M |
| Operating cash flow | 38.90%134.99M | 2.50%97.19M | 61.94%94.81M | 28.54%58.55M | -21.04%45.55M | -3.09%57.68M | -25.29%59.52M | 57.01%79.68M | -18.59%50.75M | 92.91%62.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -16.67%-7.45M | 62.25%-6.38M | 94.68%-16.91M | -3,494.76%-317.74M | -36.30%-8.84M | 92.96%-6.49M | -1,025.10%-92.17M | 68.34%-8.19M | -211.21%-25.87M | -125.96%-8.31M |
| Net PPE purchase and sale | 7.92%-4.11M | -239.51%-4.47M | 28.44%-1.32M | 13.62%-1.84M | -150.77%-2.13M | 72.87%-849K | -134.21%-3.13M | -1.37%-1.34M | 29.33%-1.32M | -66.67%-1.87M |
| Net intangibles purchas and sale | -144.89%-4.69M | 28.98%-1.92M | -14.08%-2.7M | 64.75%-2.37M | -19.06%-6.71M | 10.35%-5.64M | -1.96%-6.29M | 16.81%-6.17M | -14.95%-7.41M | -151.88%-6.45M |
| Net business purchase and sale | --1.36M | ---- | 95.89%-12.9M | ---313.54M | ---- | ---- | -11,893.04%-82.75M | 95.97%-690K | ---17.14M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -16.67%-7.45M | 62.25%-6.38M | 94.68%-16.91M | -3,494.76%-317.74M | -36.30%-8.84M | 92.96%-6.49M | -1,025.10%-92.17M | 68.34%-8.19M | -211.21%-25.87M | -125.96%-8.31M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -4.30%-116.94M | -79.93%-112.12M | -122.47%-62.31M | 522.67%277.3M | -54.24%-65.61M | -242.95%-42.54M | 161.12%29.76M | -223.20%-48.68M | 45.60%-15.06M | -35.28%-27.69M |
| Net issuance payments of debt | 15.38%-55M | -116.58%-65M | -126.09%-30.01M | 560.05%115.01M | ---25M | ---- | --60M | ---- | ---- | ---- |
| Net common stock issuance | -44.30%-5.96M | ---4.13M | ---- | --179.02M | ---- | -1,155.93%-741K | 99.78%-59K | -575.65%-26.61M | -629.26%-3.94M | 82.47%-540K |
| Cash dividends paid | -66.33%-30.67M | -99.61%-18.44M | ---9.24M | ---- | 20.89%-28.72M | -21.76%-36.3M | -37.25%-29.82M | -98.39%-21.72M | -41.88%-10.95M | -300.73%-7.72M |
| Net other financing activities | -3.09%-25.31M | -6.46%-24.55M | -37.79%-23.06M | 29.60%-16.74M | -116.50%-23.78M | -1,388.08%-10.98M | -4.53%-738K | -101.71%-706K | 98.20%-350K | ---19.43M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -4.30%-116.94M | -79.93%-112.12M | -122.47%-62.31M | 522.67%277.3M | -54.24%-65.61M | -242.95%-42.54M | 161.12%29.76M | -223.20%-48.68M | 45.60%-15.06M | -35.28%-27.69M |
| Net cash flow | ||||||||||
| Beginning cash position | -25.30%62.95M | 22.70%84.27M | 35.80%68.68M | -36.36%50.57M | 12.23%79.47M | -3.92%70.81M | 44.80%73.7M | 23.88%50.9M | 178.44%41.09M | 123.92%14.76M |
| Current changes in cash | 149.75%10.61M | -236.75%-21.32M | -13.89%15.59M | 162.65%18.1M | -433.59%-28.9M | 399.86%8.66M | -112.67%-2.89M | 132.40%22.8M | -62.74%9.81M | 222.43%26.33M |
| End cash Position | 16.85%73.55M | -25.30%62.95M | 22.70%84.27M | 35.80%68.68M | -36.36%50.57M | 12.23%79.47M | -3.92%70.81M | 44.80%73.7M | 23.88%50.9M | 178.44%41.09M |
| Free cash from | 40.57%121.89M | -0.13%86.71M | 63.31%86.83M | 49.13%53.17M | -28.50%35.65M | 0.42%49.86M | -30.97%49.66M | 71.68%71.94M | -20.62%41.9M | 85.51%52.78M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |